Similar to TRPV6 and TRPV2 (poor prognosis with high expression in numerous cancers), high expression of the PM Ca2+ ATPase 2 (PMCA2) conferred resistance to apoptosis and was associated with a poor prognosis [32]. This evidence concerns the gene TRPV6 and cancer.